Skip to main content
. 2025 Aug 14;18(8):1198. doi: 10.3390/ph18081198
ABC ATP-binding cassette
ADCC Antibody-dependent cell-mediated cytotoxicity
ADC Antibody-drug conjugate
ADMET Absorption, Distribution, Metabolism, Excretion, and Toxicity
AML Acute myeloid leukemia
AOC Antibody oligonucleotide conjugate
cBu Cyclobutane-1,1-dicarboxamide
CDR Complementarity-determining region
CEA Carcinoembryonic antigen
CH Heavy chain constant domain
CL Light chain constant domain
CPP-scFv Cell-penetrating peptide single-chain variable fragment
DAR Drug-Antibody ratio
DM1 Mertansine
DXd Deruxtecan
ECM Extracellular matrix
EGFR Epidermal growth factor receptor
Fab Antigen-binding fragment
Fc Crystallizable fragment
FcRn Neonatal Fc receptor
Fv Variable fragment of antibody
GCC Guanylyl cyclase C
GSH Glutathione
HCs Heavy chains
HER2 Human Epidermal Growth Factor Receptor 2
H3-OPT CDR-H3 optimization toolkit
HR Homologous recombination
IC50 Half-maximal inhibitory concentration
IgG Immunoglobulin G
LC Light chain
Lys-MCC-DM1 Lysine-linked maytansinoid metabolite
mAb Monoclonal antibody
MDR1 Multidrug resistance protein 1
MD Molecular dynamics
MMAE Monomethyl auristatin E
MSA Multiple Sequence Alignment
NAMPT Nicotinamide phosphoribosyltransferase
NHEJ Non-homologous end joining
PABC Para-aminobenzyl carbamate
PBD Pyrrolobenzodiazepine
PEG Polyethylene glycol
pLDDT Predicted Local Distance Difference Test
PROTAC Proteolysis Targeting Chimera
RAbD RosettaAntibodyDesign
scFv Single-chain variable fragment
SMCC Succinimidyl-4-(N-maleimidomethyl) cyclohexane-1-carboxylate
STING Stimulator of Interferon Genes
TAP Therapeutic Antibody Profiler
T-DM1 Trastuzumab emtansine
TME Tumor microenvironment
VH Variable heavy chain domain
VL Variable light chain domain